Using bone marrow mesenchymal stem cells to treat liver diseases / 中华肝胆外科杂志
Chinese Journal of Hepatobiliary Surgery
;
(12): 564-566, 2012.
Artículo
en Chino
| WPRIM
| ID: wpr-426621
ABSTRACT
Primary hepatocellular carcinoma progresses from liver fibrosis and cirrhosis to eventually result in liver failure and distant metastasis.Surgical resection is the preferred method of treatment for liver cancer while interventional treatment and liver transplantation are the choices to treat end-stage liver cancer.Unfortunately,partial hepatectomy and interventional treatment are not ideal due to the resulting consequence of hepatocyte dysfunction.Extensive clinical application of liver transplants is limited by the lack of available donors and high costs.Over the past decade,researches on bone marrow mesenchymal stem cells (BMSCs)have made remarkable achievements in the medical field.In this review,we summarize the recent progress of BMSCs in the treatment of liver diseases.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Hepatobiliary Surgery
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS